Thank you jagginit. We all really appreciate your, clydes and aug's posts.
just out of interest was there any mention of any of the following:
1. whether Carter holds to his guidance (which he confirmed in the last announcement) of two more deals this quarter? 2. Whether there was discussion about Teva and Edding - as to there progress on the applications and why Teva are not going ahead with the options 3. whether there was any clarification during the AGM about the slide on the deals. based on that slide it would be accurate to say we have 20 deals past term sheet stage i.e. 10 at term sheet, 5 in drafting and 5 completed. can you shed any light jag?
thanks again
SUD Price at posting:
0.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)